|
Short Title: Empowher
Enrollment Status: Not yet recruiting
NCT #: NCT06435429
Specialty Area: Oncology
Condition Studied: Metastatic HER2-positive Breast Cancer
Age Groups: Adult; Older Adult
Phase: III
To study treatment options for people with HER2-positive metastatic breast cancer whose cancer has grown or could not be tolerated after prior treatment. This study is comparing two HER2-targeted medications to understand how well they work and how safe they are in this setting. The goal of the study is to determine whether one treatment may better control the cancer after previous therapy has stopped working.
Location: Renown Health, Office of Clinical Research
Address:
Complete Study Details: https://clinicaltrials.gov/study/NCT06435429
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.
